Director Declaration

RNS Number : 8501T

ConvaTec Group PLC

06 July 2018

 

Reading, United Kingdom (6 July 2018) -  Further to the announcement on 3 July 2018 of the appointment of Sten Scheibye as a Non-Executive Director of ConvaTec Group Plc, it is confirmed that there are no disclosures to be made pursuant to LR 9.6.13 in relation to the appointment of Sten Scheibye.

Enquiries

Media

Bobby Leach, VP Group Corporate Affairs, ConvaTec                    [phone]

Alastair Elwen, Finsbury                                                             [phone]

Analysts and Investors

John Crosse, VP Investor Relations, ConvaTec                             [phone]

Kirsty Law, Director Investor Relations, ConvaTec                         [phone]

[e-mail]

ConvaTec Group Plc’s LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

 

END

 

 

RDNUGUMCMUPRURQ